| |
BOARD
| Advisors |
We have a strong, experienced board of advisors made up of pharmaceutical company CEOs, highly regarded clinicians and/or senior product development managers.
- Michael Burns, PhD, President & COO, Ferndale Laboratory Inc
- James Eliason, PhD, CEO, CSO, Motostem, LLC
- Terry Minton, PhD, CEO, Naprogenix Inc, Former CEO, Aptamera Inc (An oncology startup acquired during Phase I clinical trials)
- Stephen Munk, PhD, CEO, Ash Stevens Inc
- Louis Scarmoutzos, PhD, President, MVS Solutions, executive consulting & Principal Advisor to the NIH-CAP program
- Charles Schiffer, MD, Oncologist, Karmanos Cancer Institute
|
|
|
|
|
|
|
|
|
| |
| |
| |
|
|
